RESUMEN
OBJECTIVE: To compare the discriminative performances of the 2018 National Institutes of Health (NIH) and the 2019 Jensen definitions of bronchopulmonary dysplasia (BPD) with the 2001 NIH definition on adverse neurodevelopmental and respiratory outcomes at 2 years and 5 years corrected age. STUDY DESIGN: In this single-center retrospective cohort study, outcomes of infants born at <30 weeks of gestational age were collected. The 3 definitions of BPD were compared by adding the different definitions to the National Institute of Child Health and Human Development's outcome prediction model for neurodevelopmental impairment (NDI) or death. Discriminative performance was compared for both outcomes at 2 years and 5 years corrected age by calculating the areas under the receiver operating characteristic curve and z-statistics. RESULTS: The presence of BPD and its severity were determined in 584 infants. There were considerable shifts in BPD grading among the different definitions. At both time points, all BPD definition models had comparable discriminating power for NDI and respiratory morbidity, with one exception. Compared with the 2001 NIH definition, the 2018 NIH definition had less predictive power for the neurologic outcome at 2 years corrected age. CONCLUSIONS: Our comparison of the 3 BPD definitions shows similar discriminative performance on long term neurodevelopmental and respiratory outcomes at 2 years and 5 years corrected age.
Asunto(s)
Displasia Broncopulmonar , Recien Nacido Prematuro , Lactante , Niño , Recién Nacido , Humanos , Displasia Broncopulmonar/diagnóstico , Estudios Retrospectivos , Edad Gestacional , PronósticoRESUMEN
In Europe, several national networks have been established to undertake clinical research of medicines for children. In the Netherlands, the Dutch Medicines for Children Research Network (MCRN) was launched in September 2008. The purpose of the Dutch MCRN is to improve the speed, quality, and coordination of clinical drug research in children, ultimately resulting in better patient care.